Xilio Therapeutics, Inc. - XLO

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$25.42M
QoQ value delta ($000)
+$8.057M (+46.42%)
Implied price effect (QoQ)
-24.16%
Shares
Total shares
39,727,815
QoQ shares delta
+19,151,020 (+93.07%)
Total shares held by funds (by quarter)

Market chart (XLO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
GILEAD SCIENCES, INC. 5,829 9,105,451 0.3%
Bain Capital Life Sciences Investors, LLC 4,719 7,372,686 0.36%
Frazier Life Sciences Management, L.P. 3,786 5,915,091 0.1%
Point72 Asset Management, L.P. 2,560 4,000,000 0.0%
Sio Capital Management, LLC 1,366 2,134,537 0.21%
STEMPOINT CAPITAL LP 1,299 2,030,028 0.22%
Merck & Co., Inc. 949 1,483,758 0.34%
VANGUARD GROUP INC 803 1,255,692 0.0%
Empery Asset Management, LP 757 1,183,040 0.67%
Ghisallo Capital Management LLC 712 1,113,222 0.03%
MORGAN STANLEY 537 839,850 0.0%
AJU IB Investment Co., Ltd. 427 667,742 1.88%
FMR LLC 327 511,820 0.0%
CITADEL ADVISORS LLC 279 436,216 0.0%
RENAISSANCE TECHNOLOGIES LLC 220 344,416 0.0%
GEODE CAPITAL MANAGEMENT, LLC 210 328,972 0.0%
STATE STREET CORP 119 186,390 0.0%
Velan Capital Investment Management LP 108 170,000 0.06%
GSA CAPITAL PARTNERS LLP 95 147,966 0.01%
Stonepine Capital Management, LLC 80 126,270 0.06%
NORTHERN TRUST CORP 42 66,609 0.0%
TWO SIGMA INVESTMENTS, LP 39 62,032 0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35 56,081 0.0%
JANE STREET GROUP, LLC 26 42,080 0.0%
HRT FINANCIAL LP 20 31,886 0.0%